Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2

I Samman1, W J Schulz-Schaeffer, J C Wöhrle

  • 1Department of Neurology, Klinikum Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer, 68135 Mannheim, Germany.

Insights

This case study highlights a rare presentation of sporadic Creutzfeldt-Jakob disease (sCJD) in a 68-year-old woman. Despite atypical diagnostic markers, advanced MRI revealed characteristic brain changes, underscoring the need to consider sCJD even with unusual features.

Area of Science:

  • Neurology
  • Neuroscience
  • Prion Diseases

Background:

  • Creutzfeldt-Jakob disease (CJD) is a rapidly progressive neurodegenerative disorder.
  • Diagnosis typically relies on characteristic EEG, CSF biomarkers (14-3-3, NSE), and MRI findings.
  • Genetic factors, including PRNP codon 129 polymorphism, influence CJD phenotypes.

Observation:

  • A 68-year-old woman presented with ataxia, rapidly progressive dementia, myoclonus, and SIADH.
  • She lacked typical EEG abnormalities and positive CSF biomarkers for 14-3-3 or neuron-specific enolase (NSE).
  • MRI revealed significant hyperintense signals in cortical layers and basal ganglia, correlating with spongiform degeneration.

Findings:

  • Molecular analysis showed PRNP codon 129 heterozygosity (Met/Val) and PrP(CJD) type 2.
  • Striking cortical MRI hyperintensities were observed, mirroring histopathological changes.
  • The patient exhibited atypical features including SIADH and sensorimotor polyneuropathy.

Implications:

  • This case expands the spectrum of clinical and imaging presentations of sporadic CJD.
  • It emphasizes the importance of considering CJD in rapidly progressive dementia, even with atypical diagnostic test results.
  • Advanced MRI findings can be crucial for diagnosing CJD when traditional markers are negative.

Related Concept Videos